This review focuses on the role of cyclooxygenases in reproductive medicine and biology. The cyclooxygenase enzymes catalysis the role-limiting reactions for prostaglandins and thromboxame synthesis. Two separate isoforms, COX-1 and COX-2, are present, and differences in their roles are discussed in the context of inflammation and parturition.
1. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J1998;12:1063-1073.
2.
2. Davies P, MacIntyre DE. Prostaglandins and inflammation. In: Gallin JI, Goldstein IM, Synderman R, eds. Inflammation: Basic principles and clinical correlates. 2nd ed.New York: Raven Press, Ltd.1992;123-138.
3.
3. Keirse MJNC. Eicosanoids in human pregnancy and parturition. In: Mitchell MD, ed. Eicosanoids in reproduction. Boca Raton: CRC Press, 1990:199-222.
4.
4. Cameron IT. Prostaglandins and menstruation. In: Drife JO, Calder AA, ed. Prostaglandins and the uterus. London: Springer-Verlag, 1992:17-32.
5.
5. Smith SK. Prostaglandins and implantation. In: Drife JO, Calder AA, eds. Prostaglandins and the uterus. London: Springer-Verlag, 1992:91-99.
6.
6. Needleman P, Turk J, Jackschik BA, Morriosn AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem1986;55:69-102.
7.
7. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta1991;1083:1-17.
8.
8. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J1989;259:315-324.
9.
9. Meagher EA, FitzGerald GA. The molecular basis of eicosanoid action. Hypertens Pregnancy1993;12:439-451.
10.
10. Raz A, Wyche A, Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A1989;86:1657-1661.
11.
11. Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol1997;24(Suppl 49):6-8.
12.
12. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A1991;88:2692-2696.
13.
13. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem1991;266:12866-12872.
14.
14. O'Banion MK, Sadowski HB, Winn V, Young DA. A serumand glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem1991;266:23261-23267.
15.
15. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell1986;46:659-667.
16.
16. Kraemer SA, Meade EA, DeWitt DLProstaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch Biochem Biophys1992;293:391-400.
17.
17. Wein PZ, Warden C, Fletcher BS, Kujubu DA, Herschman HR, Lusis AJ. Chromosomal organization of the inducible and consitutive prostaglandin synthase/cyclooxygenase genes in mouse. Genomics1993;15:458-460.
18.
18. Egan RW, Paxton J, Kuchl FA Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem1976;251:7329-7335.
19.
19. Otto JC, DeWitt DL, Smith WL. N-glycosylation of prostaglandin endoperoxide synthase-1 and -2 and their orientations in the endolpasmic reticulum. J Biol Chem1993;26:18234-18242.
20.
20. Wang LH, Hjibeigi A, Xu Xm, Loose-Mitchell D, Wu KK. Characterization of the promoter of human prostaglandin Hy synthase-1 gene. Biochem Biophys Res Commun1993;190:406-411.
21.
21. Gou Q, Liu CH, Ben-Av P, Hla T. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun1998;242:508-512.
22.
22. Hansen WR, Sato T, Mitchell MD. Tumour necrosis factoralpha stimulates increased expression of prostaglandin endoperoxide H synhthase type 2 mRNA in amnion-derived WISH cells. J Mol Endocrinol1998;20:221-231.
23.
23. Herschman HR, Kujubu DA, Fletcher BS, et al. The ris genes, primary response genes induced by growth factor and tumor promoters in 3T3 cells. Prog Nucleic Acids Res Mol Biol1994;47:113-148.
24.
24. Adams J, Collaco-Moraes Y, de Belleroche J. Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation. J Neurochem1996;66:6-13.
25.
25. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM, Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease. Exp Neurol1997;144:339-349.
26.
26. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF, Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron1993;11:371-386.
27.
27. Kaufman WE, Worley PF, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A1996;93:2317-2321.
28.
28. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci1997;17:2746-2755.
29.
29. Walenga RW, Kester M, Coroneos E, Butcher S, Dwivedi R, Statt C. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro. Prostaglandins1996;52;341-359.
30.
30. Battistini B, Botting R, Bakhle YS. COX-1 and COX-2: Toward the development of more selective NSAIDs. Drug News Perspect1994;7:501-512.
31.
31. Samet JM, Fasano MB, Fonteh AN, Chilton FH. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells. J Biol Chem1995;270:8044-8049.
32.
32. Brannon TS, MacRitchie AN, Jaramillo MA, et al. Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol1998;274:L66-L71.
33.
33. Brock TG, McNish RW, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem1992;274:11660-11666.
34.
34. Simmons DL, Xie W, Evett G, Merrill J, Robertson DL, Bradshaw WS. Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2. J Lipid Med1993;6:113-117.
35.
35. Irvine RF. How is the level of free arachidonic acid controlled in mammalian cells?Biochem J1982;204:3-16.
36.
36. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem1992;267:7991-7994.
37.
37. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of Il-1β-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells. Biochem Biophys Res Commun1994;202:931-939.
38.
38. Perkins DJ, Kniss DA. Tumor necrosis factor-α promotes sustained cyclooxygenase-2 expression: Attenuation by dexamethasone and NSAIDs. Prostaglandins1997;54:727-743.
39.
39. Imseis HM, Zimmerman PD, Samuels P, Kniss DA. Tumour necrosis factor-α induces cyclo-oxygenase-2 gene expression in first trimester trophobasts: Supression by glucocorticoids and NSAIDs. Placenta1997;18:521-526.
40.
40. Zakar T, Olson DM. Studies on glucocorticoid hormone actions in the regulation of human amnion PGHS. Reprod Fertil Dev1995;7:517-520.
41.
41. Simon LS. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol1995;7:159-166.
42.
42. Smith WL, Meade EA, DeWitt DL. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci1994;714:136-142.
47. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. New Engl J Med1993;329:1602-1607.
48.
48. Gordon MC, Samuels P. Indomethacin tocolysis-benefits versus risks. Clin Obstet Gynecol1995;38:697-705.
49.
49. Ben-David Y, Hallak M, Rotschild A, et al. Indomethacin and fetal ductus arteriosus: Complete closure after cessation of prolonged therapeutic course. Fetal Diagn Ther1996;11:341-344.
50.
50. Brannon TS, North AJ, Wells LB, Shaul PW. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest1994;93:2230-2235.
51.
51. Sawdy R, Slater D, Fisk N, Edmonds DK, Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet1997;350:265-266.
52.
52. Smith WL, DeWitt DL. Prostaglandin endoperoxide H synthase-1 and -2. Adv Immunol1996;62:167-215.
53.
53. Seibert K, Masferret J, Zhang Y, et al. Mediation of inflammation by cyclooxygenase-2. Agents Actions1995;46:41-50.
54.
54. Jouzeau JY, Terlain B, Abid A, Nedelec E, Netter P. Cycloxygenase isoenzymes: How recent findings affect thinking about nonsteroidal ant-inflammatory drugs. Drugs1997;53:563-582.
55.
55. Parret ML, Harris RE, Joarder FS, Ross MS, Clausen KP, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol1997;10:503-507.
56.
56. Levy GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J1997;11:234-247.
57.
57. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res1997;57:1276-1280.
58.
58. Yee GM, Squires PM, Cejic SS, Kennedy TG. Lipid mediators of implantation and decidualization. J Lipid Med1993;6:525-534.
59.
59. Marsliburn PB, Shabanowtiz RB, Clark MR. Immunohisto-chemical localization of prostaglandin H synthase in the embryo and uterus of the mouse from ovulation through implantation. Mol Reprod Dev1990;25:309-316.
60.
60. Holmes PV, Sjogren A, Hamberger L. Prostaglandin-E2 released by pre-implantation human conceptuses. J Reprod Immunol1990;17:79-86.
61.
61. Ksamo M, Ishidawa M, Yamashita K, Sengoku K, Shimizu T. Possible role of prostaglandin F in blastocyst implantation. Prostaglandins1986;31:321-336.
62.
62. Yang ZM, Das SK, Wang J, Sugimoto Y, Ichikawa A, Dey SK. Potential sites of prostaglandin actions in the periimplantation mouse uterus: Diffeential expression and regulation of prostaglandin receptor genes. Biol Reprod1997;56:368-379.
63.
63. Wu Wx, Owiny J, Zhang Q, Ma XH, Nathanielsz PW. Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometerium: The role of estradiol and progesterone. Biol Reprod1996;55:762-768.
64.
64. Wu Wx, Ma XH, Zhang Q, Buchwalder L, Nathanielsz PW. Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo. Endocrinology1997;138:4005-4012.
65.
65. Kennard EA, Zimmerman PD, Friedman CI, Kniss DA. Inter-leukin-1β induces cyclooxygenase-2 in cultured human decidual cells. Am J Reprod Immunol1995;34:65-71.
66.
66. Kniss DA, Zimmerman PD, Garver CL, Fertel RH. Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium. Am J Obstet Gyunecol1997;177:559-567.
67.
67. Chakraborty I, Das SK, Wang J, Dey SK. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the pen-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol1996;16:107-122.
68.
68. Dong YL, Gangula PRR, Fang L, Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrus cycle, pregnancy, and in myometrial cells. Prostaglandins1996;52:13-34.
69.
69. Langenbach R, Morham SG, Tiano HF, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell1995;83:483-492.
70.
70. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell1997;91:197-208.
71.
71. Morham SG, Langenbach R, Loftin CD, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell1995;83:473-482.
72.
72. Slater D, Berger L, Newton R, Moore G, Bennett P. The relative abundance of type 1 and type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun1994;198:304-308.
73.
73. Gross GA, Imamura T, Luedke C, et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci U S A1998;95:11875-11879.
74.
74. Swaisgood CM, Zu HX, Perkins DJ, et al. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice. Am J Obstet Gynecol1997;177:1253-1262.
75.
75. Silver RM, Edwin SS, Trautman MS, et al. Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest1995;95:725-731.
76.
76. Kniss DA, Zimmerman PD, Gabbe SG, Iams JD. Selective ablation of cyclooxygenase-2 gene expression and prostaglandin biosynthesis by antisense phosphorthioates. J Soc Gynecol Invest1996;3(Suppl):95A-95A.
77.
77. Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPAR-α but not by PPAR-gamma activators. Nature1998;393:790-793.
78.
78. Kniss DA, Boswell HB, Zimmerman PD. Peroxisome proliferator-activated receptor agonists inhibit cyclooxygenase-2 gene expression in ED27 human trophoblasts. J Soc Gynecol Invest1999;6(Suppl):52A-52A.
79.
79. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med1999;5:698-701.
